• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由酚-酚盐超分子杂合成环体维持的离子共晶体的晶体工程

Crystal Engineering of Ionic Cocrystals Sustained by the Phenol-Phenolate Supramolecular Heterosynthon.

作者信息

Jin Shasha, Sanii Rana, Song Bai-Qiao, Zaworotko Michael J

机构信息

Department of Chemical Sciences and Bernal Institute, University of Limerick, Co., Limerick V94 T9PX, Ireland.

出版信息

Cryst Growth Des. 2022 Jul 6;22(7):4582-4591. doi: 10.1021/acs.cgd.2c00471. Epub 2022 Jun 21.

DOI:10.1021/acs.cgd.2c00471
PMID:35935703
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9347308/
Abstract

Although crystal engineering strategies are generally well explored in the context of multicomponent crystals (cocrystals) formed by neutral coformers (molecular cocrystals), cocrystals comprised of one or more salts (ionic cocrystals, ICCs) are understudied. We herein address the design, preparation, and structural characterization of ICCs formed by phenolic moieties, a common group in natural products and drug molecules. Organic and inorganic bases were reacted with the following phenolic coformers: phenol, resorcinol, phloroglucinol, 4-methoxyphenol, and 4-isopropylphenol. Nine ICCs were crystallized, each of them sustained by the phenol-phenolate supramolecular heterosynthon (PhOH···PhO). Such ICCs are of potential utility, and there are numerous examples of phenolic compounds that are biologically active, some of which suffer from low aqueous solubility. The propensity to form ICCs sustained by the PhOH···PhO supramolecular heterosynthon was evaluated through a combination of Cambridge Structural Database (CSD) mining, structural characterization of nine novel ICCs, and calculation of interaction energies. Our analysis of these 9 ICCs and the 41 relevant entries archived in the CSD revealed that phenol groups can reliably form ICCs through charge-assisted PhOH···PhO interactions. This conclusion is supported by hydrogen-bond strength calculations derived from CrystalExplorer that reveal the PhOH···PhO interaction to be around 3 times stronger than the phenol-phenol hydrogen bond. The PhOH···PhO supramolecular heterosynthon could therefore enable crystal engineering studies of a large number of phenolic pharmaceutical and nutraceutical compounds with their conjugate bases.

摘要

尽管在由中性共形成物形成的多组分晶体(共晶体)(分子共晶体)的背景下,晶体工程策略通常已得到充分探索,但由一种或多种盐组成的共晶体(离子共晶体,ICCs)却研究不足。我们在此阐述了由酚类部分形成的ICCs的设计、制备和结构表征,酚类部分是天然产物和药物分子中的常见基团。有机碱和无机碱与以下酚类共形成物反应:苯酚、间苯二酚、间苯三酚、4-甲氧基苯酚和4-异丙基苯酚。九个ICCs结晶出来,它们每个都由酚-酚盐超分子异合成子(PhOH···PhO)维持。此类ICCs具有潜在用途,并且有许多酚类化合物具有生物活性的例子,其中一些存在水溶解度低的问题。通过结合剑桥结构数据库(CSD)挖掘、九个新型ICCs的结构表征以及相互作用能的计算,评估了由PhOH···PhO超分子异合成子维持形成ICCs的倾向。我们对这9个ICCs以及CSD中存档的41个相关条目进行分析后发现,酚基可通过电荷辅助的PhOH···PhO相互作用可靠地形成ICCs。这一结论得到了来自CrystalExplorer的氢键强度计算的支持,该计算表明PhOH···PhO相互作用比酚-酚氢键强约3倍。因此,PhOH···PhO超分子异合成子可用于对大量酚类药物和营养保健品及其共轭碱进行晶体工程研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/8d6cf9a2ca16/cg2c00471_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/59ed9bd00574/cg2c00471_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/b03a445e5f08/cg2c00471_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/a33f5a317d5f/cg2c00471_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/afccf8f4c8b5/cg2c00471_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/f3639138a477/cg2c00471_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/67422eb1504a/cg2c00471_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/e2f747f18866/cg2c00471_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/351c01eee33e/cg2c00471_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/8d6cf9a2ca16/cg2c00471_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/59ed9bd00574/cg2c00471_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/b03a445e5f08/cg2c00471_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/a33f5a317d5f/cg2c00471_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/afccf8f4c8b5/cg2c00471_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/f3639138a477/cg2c00471_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/67422eb1504a/cg2c00471_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/e2f747f18866/cg2c00471_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/351c01eee33e/cg2c00471_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de99/9347308/8d6cf9a2ca16/cg2c00471_0010.jpg

相似文献

1
Crystal Engineering of Ionic Cocrystals Sustained by the Phenol-Phenolate Supramolecular Heterosynthon.由酚-酚盐超分子杂合成环体维持的离子共晶体的晶体工程
Cryst Growth Des. 2022 Jul 6;22(7):4582-4591. doi: 10.1021/acs.cgd.2c00471. Epub 2022 Jun 21.
2
Crystal Engineering of Ionic Cocrystals Sustained by Azolium···Azole Heterosynthons.由唑鎓···唑杂合成子支撑的离子共晶体的晶体工程
Pharmaceutics. 2022 Oct 28;14(11):2321. doi: 10.3390/pharmaceutics14112321.
3
Crystal engineering of ionic cocrystals comprising Na/K salts of hesperetin with hesperetin molecules and solubility modulation.包含橙皮素分子的橙皮素钠/钾盐离子共晶的晶体工程与溶解度调节
IUCrJ. 2023 May 1;10(Pt 3):329-340. doi: 10.1107/S205225252300266X.
4
Supramolecular Synthon Promiscuity in Phosphoric Acid-Dihydrogen Phosphate Ionic Cocrystals.磷酸-磷酸二氢根离子共晶体中的超分子合成子混杂现象。
Cryst Growth Des. 2022 May 4;22(5):3333-3342. doi: 10.1021/acs.cgd.2c00150. Epub 2022 Apr 19.
5
Hierarchy of supramolecular synthons: persistent hydroxyl...pyridine hydrogen bonds in cocrystals that contain a cyano acceptor.超分子合成子的层级结构:含氰基受体的共晶体中持久的羟基……吡啶氢键。
Mol Pharm. 2007 May-Jun;4(3):401-16. doi: 10.1021/mp070012s. Epub 2007 May 15.
6
Pharmaceutical cocrystals: along the path to improved medicines.药物共晶体:迈向改良药物之路
Chem Commun (Camb). 2016 Jan 14;52(4):640-55. doi: 10.1039/c5cc08216a.
7
Cocrystals, Salts, and Salt-Solvates of olanzapine; selection of coformers and improved solubility.奥氮平共晶、盐和盐溶剂化物;共晶形成剂的选择和溶解度的提高。
Int J Pharm. 2021 Oct 25;608:121063. doi: 10.1016/j.ijpharm.2021.121063. Epub 2021 Sep 1.
8
The phenoxy/phenol/copper cation: a minimalistic model of bonding relations in active centers of mononuclear copper enzymes.苯氧基/苯酚/铜阳离子:单核铜酶活性中心键合关系的极简模型。
Chemistry. 2008;14(14):4318-27. doi: 10.1002/chem.200800052.
9
Strategy and Methodology in the Synthesis of Multicomponent Molecular Solids: The Quest for Higher Cocrystals.多组分分子固体的合成策略与方法学:追求更高共晶的探索。
Acc Chem Res. 2019 Aug 20;52(8):2210-2220. doi: 10.1021/acs.accounts.9b00211. Epub 2019 Jul 18.
10
Amide-N-oxide heterosynthon and amide dimer homosynthon in cocrystals of carboxamide drugs and pyridine N-oxides.羧酰胺类药物与吡啶氮氧化物共晶体中的酰胺 -N-氧化物杂合成子和酰胺二聚体同合成子。
Mol Pharm. 2007 May-Jun;4(3):417-34. doi: 10.1021/mp070014c. Epub 2007 May 12.

引用本文的文献

1
Crystal engineering of ionic cocrystals comprising Na/K salts of hesperetin with hesperetin molecules and solubility modulation.包含橙皮素分子的橙皮素钠/钾盐离子共晶的晶体工程与溶解度调节
IUCrJ. 2023 May 1;10(Pt 3):329-340. doi: 10.1107/S205225252300266X.
2
Crystal Engineering of Ionic Cocrystals Sustained by Azolium···Azole Heterosynthons.由唑鎓···唑杂合成子支撑的离子共晶体的晶体工程
Pharmaceutics. 2022 Oct 28;14(11):2321. doi: 10.3390/pharmaceutics14112321.
3
Conformational Trimorphism in an Ionic Cocrystal of Hesperetin.橙皮素离子共晶体中的构象三态性。

本文引用的文献

1
Steps towards a nature inspired inorganic crystal engineering.迈向受自然启发的无机晶体工程。
Dalton Trans. 2022 May 17;51(19):7390-7400. doi: 10.1039/d2dt00834c.
2
Improving stability of the metal-free primary energetic cyanuric triazide (CTA) through cocrystallization.通过共晶作用提高无金属基主能氰尿酸三嗪(CTA)的稳定性。
Chem Commun (Camb). 2020 Feb 18;56(14):2111-2114. doi: 10.1039/c9cc09465b. Epub 2020 Jan 22.
3
A novel cocrystal composed of CL-20 and an energetic ionic salt.一种由 CL-20 和高能离子盐组成的新型共晶。
Cryst Growth Des. 2022 Nov 2;22(11):6390-6397. doi: 10.1021/acs.cgd.2c00861. Epub 2022 Oct 4.
Chem Commun (Camb). 2018 Nov 22;54(94):13268-13270. doi: 10.1039/c8cc06540c.
4
DrugBank 5.0: a major update to the DrugBank database for 2018.DrugBank 5.0:2018 年 DrugBank 数据库的重大更新。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037.
5
Improving Biopharmaceutical Properties of Vinpocetine Through Cocrystallization.通过共结晶改善长春西汀的生物制药性能。
J Pharm Sci. 2016 Dec;105(12):3626-3633. doi: 10.1016/j.xphs.2016.09.017. Epub 2016 Oct 24.
6
Pharmaceutical cocrystals: along the path to improved medicines.药物共晶体:迈向改良药物之路
Chem Commun (Camb). 2016 Jan 14;52(4):640-55. doi: 10.1039/c5cc08216a.
7
Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Patients with Heart Failure.恩格列净(沙库巴曲/缬沙坦):首个获批用于心力衰竭患者的血管紧张素受体脑啡肽酶抑制剂。
Am Health Drug Benefits. 2015 Sep;8(6):330-4.
8
The hydrogen bond strength of the phenol-phenolate anionic complex: a computational and photoelectron spectroscopic study.苯酚-酚盐阴离子络合物的氢键强度:一项计算与光电子能谱研究。
Phys Chem Chem Phys. 2015 Oct 14;17(38):25109-13. doi: 10.1039/c5cp04754d.
9
Accurate and Efficient Model Energies for Exploring Intermolecular Interactions in Molecular Crystals.用于探索分子晶体中分子间相互作用的精确高效模型能量
J Phys Chem Lett. 2014 Dec 18;5(24):4249-55. doi: 10.1021/jz502271c. Epub 2014 Nov 26.
10
Antioxidant and anti-inflammatory potential of hesperetin metabolites obtained from hesperetin-administered rat serum: an ex vivo approach.橙皮苷代谢产物的抗氧化和抗炎潜力:来自橙皮苷给药大鼠血清的体外研究。
J Agric Food Chem. 2012 Jan 11;60(1):522-32. doi: 10.1021/jf2040675. Epub 2011 Dec 9.